Clin2
NCT02806388Possibly a fitRecruiting

Molecular testing to match you to the right cancer trial

Solid Tumor

Part of Cancer clinical trials.

This trial uses a tissue sample from your tumor to look for specific molecular changes, then helps match you to available clinical trials. It may help by directing treatment research toward tumors most likely to benefit.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5,500 people
Ages
12 years and older
Study type
Observational

Who can take part

  • You have a confirmed solid-tumor cancer diagnosis (not a blood cancer).
  • Your doctor thinks you’re well enough to receive regular cancer treatments and join clinical trials.
  • Your physical functioning score is less than 2 (meaning you can do daily activities most of the time).
  • You can provide a tumor tissue sample for molecular testing.
  • You can understand the study information and sign the consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05585684Recruiting
Blood test to guide next cancer treatment choices

This study checks whether a blood test can find tumor genetic changes (called “plasma genomic profiling”) to help choose the best next treatment. It may help your care team decide therapy after your cancer progresses or seems likely to progress soon.

Baltimore, Maryland
NCT02906943Recruiting
Testing cancer tissue to guide targeted treatment choices

This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.

Hamilton, Ontario
NCT01772771Recruiting
Molecular testing to guide personalized cancer treatment plans

This trial uses special lab tests to look for tumor “molecular fingerprints” in your tumor or blood sample. The goal is to help your care team choose more personalized treatment options based on those results.

Houston, Texas
NCT04510766Recruiting
Test tumor genetic results to guide early trial treatments

This trial looks at your tumor’s genetic information from stored tissue to help match you to early-phase treatment options. It may help doctors find a therapy that fits your tumor, especially when standard options have limited benefit.

Bellinzona
NCT05564377Recruiting· Phase 2
Find targeted cancer treatments using genetic testing

This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.

Birmingham, Alabama
NCT02215928Recruiting
Using tumor genetic tests to guide treatment choices

This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.

Palo Alto, California

Hear when a new Solid Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.